Large collaborative registries and real-world data to manage amyloid-related imaging abnormalities
To the Editor Hall et al describe a patient with prodromal Alzheimer disease who developed 6 relapsing episodes of amyloid-related imaging abnormality edema (ARIA-E) over 44 months of treatment within the aducanumab long-term extension period. Together with the recently reported 41.3% risk of ARIA i...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
April 25, 2022
|
| In: |
JAMA neurology
Year: 2022, Jahrgang: 79, Heft: 6, Pages: 633-634 |
| ISSN: | 2168-6157 |
| DOI: | 10.1001/jamaneurol.2022.0731 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/jamaneurol.2022.0731 Verlag, lizenzpflichtig, Volltext: https://jamanetwork.com/journals/jamaneurology/fullarticle/2791266 
|
| Verfasserangaben: | Fabrizio Piazza, Lutz Frölich, Alessandro Padovani |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1879990423 | ||
| 003 | DE-627 | ||
| 005 | 20240307080055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240205s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamaneurol.2022.0731 |2 doi | |
| 035 | |a (DE-627)1879990423 | ||
| 035 | |a (DE-599)KXP1879990423 | ||
| 035 | |a (OCoLC)1425215549 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Piazza, Fabrizio |e VerfasserIn |0 (DE-588)1318375843 |0 (DE-627)1879990911 |4 aut | |
| 245 | 1 | 0 | |a Large collaborative registries and real-world data to manage amyloid-related imaging abnormalities |c Fabrizio Piazza, Lutz Frölich, Alessandro Padovani |
| 264 | 1 | |c April 25, 2022 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.02.2024 | ||
| 520 | |a To the Editor Hall et al describe a patient with prodromal Alzheimer disease who developed 6 relapsing episodes of amyloid-related imaging abnormality edema (ARIA-E) over 44 months of treatment within the aducanumab long-term extension period. Together with the recently reported 41.3% risk of ARIA in the Phase 3 Study of Aducanumab in Early Alzheimer’s Disease (EMERGE and ENGAGE) trials, we believe this work is of particular interest as it points out ARIA as a timely research and clinical priority, prompting the urgent need to define standardized guidelines for the treatment and follow-up monitoring of such side events. | ||
| 700 | 1 | |a Frölich, Lutz |d 1956- |e VerfasserIn |0 (DE-588)1028327099 |0 (DE-627)730567516 |0 (DE-576)375813160 |4 aut | |
| 700 | 1 | |a Padovani, Alessandro |e VerfasserIn |0 (DE-588)131837779X |0 (DE-627)1879991365 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA neurology |d Chicago, Ill. : American Medical Association, 2013 |g 79(2022), 6, Seite 633-634 |h Online-Ressource |w (DE-627)736004785 |w (DE-600)2701924-X |w (DE-576)378726552 |x 2168-6157 |7 nnas |a Large collaborative registries and real-world data to manage amyloid-related imaging abnormalities |
| 773 | 1 | 8 | |g volume:79 |g year:2022 |g number:6 |g pages:633-634 |g extent:2 |a Large collaborative registries and real-world data to manage amyloid-related imaging abnormalities |
| 787 | 0 | 8 | |i Ergänzung zu |a Hall, JN |t Six recurrent amyloid-related imaging abnormality episodes in a patient treated with aducanumab, in: JAMA Neurol. |d 2022 |g Vol. 79(1), 87-89 |o 10.1001/jamaneurol.2021.3933 |
| 856 | 4 | 0 | |u https://doi.org/10.1001/jamaneurol.2022.0731 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://jamanetwork.com/journals/jamaneurology/fullarticle/2791266 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240205 | ||
| 993 | |a Editorial | ||
| 994 | |a 2022 | ||
| 998 | |g 1028327099 |a Frölich, Lutz |m 1028327099:Frölich, Lutz |d 60000 |e 60000PF1028327099 |k 0/60000/ |p 2 | ||
| 999 | |a KXP-PPN1879990423 |e 447653595X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Fabrizio Piazza, Lutz Frölich, Alessandro Padovani"]},"physDesc":[{"extent":"2 S."}],"recId":"1879990423","relHost":[{"id":{"zdb":["2701924-X"],"issn":["2168-6157"],"eki":["736004785"]},"recId":"736004785","physDesc":[{"extent":"Online-Ressource"}],"disp":"Large collaborative registries and real-world data to manage amyloid-related imaging abnormalitiesJAMA neurology","type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"JAMA neurology","title_sort":"JAMA neurology"}],"pubHistory":["70.2013 -"],"note":["Gesehen am 11.12.2018"],"origin":[{"publisher":"American Medical Association","dateIssuedKey":"2013","dateIssuedDisp":"2013-","publisherPlace":"Chicago, Ill."}],"part":{"volume":"79","extent":"2","pages":"633-634","year":"2022","text":"79(2022), 6, Seite 633-634","issue":"6"},"language":["eng"],"corporate":[{"display":"American Medical Association","role":"isb"}]}],"id":{"eki":["1879990423"],"doi":["10.1001/jamaneurol.2022.0731"]},"note":["Gesehen am 05.02.2024"],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"April 25, 2022"}],"title":[{"title_sort":"Large collaborative registries and real-world data to manage amyloid-related imaging abnormalities","title":"Large collaborative registries and real-world data to manage amyloid-related imaging abnormalities"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"display":"Piazza, Fabrizio","family":"Piazza","given":"Fabrizio","role":"aut"},{"display":"Frölich, Lutz","family":"Frölich","given":"Lutz","role":"aut"},{"given":"Alessandro","role":"aut","family":"Padovani","display":"Padovani, Alessandro"}]} | ||
| SRT | |a PIAZZAFABRLARGECOLLA2520 | ||